The stale, recirculated air of the Grand Majestic Hotel hummed with the low thrum of a hundred hushed conversations. Crystal chandeliers, each a miniature galaxy of glittering glass, cast fractured light across the opulent ballroom.  Here, amidst the clinking of champagne flutes and the rustling of expensive suits, Penelope Jane Holloway, a pharmaceutical sales representative for AstraZen BioTech, navigated the throngs with the practiced ease of a seasoned socialite.  Outside, a late October storm lashed against the Chicago skyline, a dramatic counterpoint to the meticulously crafted serenity within. Penelope, clutching a slim, silver briefcase containing the latest sales projections for AstraZen's groundbreaking Alzheimer's drug, felt a familiar knot of anxiety tighten in her stomach. Tonight, she wasn't just selling a product; she was selling hope. And in this room, filled with some of the most powerful neurologists in the country, hope came at a premium.
